Billy Evans, who is the partner of the famous Theranos founder Elizabeth Holmes, is diving into a new startup adventure that aims to revolutionize human health through blood testing. The New York Times got the scoop on this exciting new project called Haemanthus.
Sources spilled the beans that Haemanthus is all about using lasers to analyze blood, saliva, and urine samples in order to sniff out cancer and infections. The company is starting off by focusing on pet health first before moving on to us humans. They are on a mission to raise over $50 million to make this dream a reality.
It’s a bit like déjà vu from the whole Theranos saga, where they promised the moon and stars by conducting a bunch of medical tests with just a tiny drop of blood from a finger prick. In case you forgot, Elizabeth Holmes got herself into hot water and landed an 11-year sentence for bamboozling investors. But hey, she still believes in her dream of making healthcare more affordable for everyone. Kudos to her for not giving up!
Even the early Facebook investor, Jim Breyer, had a chance to hop on this Haemanthus train but decided to pass. He had déjà vu too, passing on Theranos not once, but twice. Guess lightning really can strike twice in the same spot.
So, are we all on the edge of our seats waiting to see if Haemanthus will be the next big thing, or will it crash and burn like its predecessor? Only time will tell. But hey, at least they’re aiming high and looking to make a difference in the world of healthcare. Let’s just hope they can deliver on their promises this time around.
